On Friday, Perspective Therapeutics Inc (AMEX: CATX) was 15.67% up from the session before settling in for the closing price of $3.00. A 52-week range for CATX has been $2.28 – $19.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 54.74%. With a float of $49.03 million, this company’s outstanding shares have now reached $67.59 million.
Let’s look at the performance matrix of the company that is accounted for 119 employees. In terms of profitability, gross margin is 3.58%, operating margin of -642.65%, and the pretax margin is -621.47%.
Perspective Therapeutics Inc (CATX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Perspective Therapeutics Inc stocks. The insider ownership of Perspective Therapeutics Inc is 27.45%, while institutional ownership is 83.57%. The most recent insider transaction that took place on Sep 12 ’24, was worth 39,500. Before that another transaction happened on Jun 17 ’24, when Company’s Chief Financial Officer bought 1,800 for $9.81, making the entire transaction worth $17,667. This insider now owns 35,971 shares in total.
Perspective Therapeutics Inc (CATX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 54.74% per share during the next fiscal year.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
You can see what Perspective Therapeutics Inc (CATX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 30.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.07 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Perspective Therapeutics Inc (AMEX: CATX) saw its 5-day average volume 5.3 million, a positive change from its year-to-date volume of 0.8 million. As of the previous 9 days, the stock’s Stochastic %D was 3.29%. Additionally, its Average True Range was 0.96.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 3.89%, which indicates a significant decrease from 5.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 291.95% in the past 14 days, which was higher than the 137.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.52, while its 200-day Moving Average is $12.74. Nevertheless, the first resistance level for the watch stands at $3.72 in the near term. At $3.98, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.37. If the price goes on to break the first support level at $3.08, it is likely to go to the next support level at $2.69. The third support level lies at $2.43 if the price breaches the second support level.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
There are 67,588K outstanding shares of the company, which has a market capitalization of 271.27 million. As of now, sales total 1,430 K while income totals -46,510 K. Its latest quarter income was 370 K while its last quarter net income were -15,120 K.
